Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
First Claim
Patent Images
1. A compound of the formula:
- ##STR3## wherein X is a C1 -C4 alkyl group and Y is H or a C1 -C4 alkyl group and Z.sup.⊕
is a pharmaceutically acceptable cation.
0 Assignments
0 Petitions
Accused Products
Abstract
The efficacy of immunotoxins having an antibody that recognizes a tumour associated antigen linked to a cytotoxin through a heterobifunctional agent of the disulphide type is improved by providing in the heterobifunctional agent a molecular grouping creating steric hindrance in relation to the disulphide link. This steric hindrance can be provided by a methyl substituted methylene group located in the heterobifunctional link adjacent to the disulphide bond.
-
Citations
4 Claims
-
1. A compound of the formula:
- ##STR3## wherein X is a C1 -C4 alkyl group and Y is H or a C1 -C4 alkyl group and Z.sup.⊕
is a pharmaceutically acceptable cation. - View Dependent Claims (2)
- ##STR3## wherein X is a C1 -C4 alkyl group and Y is H or a C1 -C4 alkyl group and Z.sup.⊕
-
3. A compound of the formula:
- ##STR4## wherein X is a C1 -C4 alkyl group and Y is H or a C1 -C4 alkyl group and Z.sup.⊕
is a pharmaceutically acceptable cation. - View Dependent Claims (4)
- ##STR4## wherein X is a C1 -C4 alkyl group and Y is H or a C1 -C4 alkyl group and Z.sup.⊕
Specification